Kempen Capital Management N.V. reduced its position in Anthem Inc (NYSE:ANTM) by 31.2% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 6,211 shares of the company’s stock after selling 2,815 shares during the period. Kempen Capital Management N.V.’s holdings in Anthem were worth $1,753,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of ANTM. Private Portfolio Partners LLC grew its stake in shares of Anthem by 34.1% during the second quarter. Private Portfolio Partners LLC now owns 986 shares of the company’s stock valued at $278,000 after acquiring an additional 251 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Anthem by 0.8% during the second quarter. Vanguard Group Inc. now owns 19,470,785 shares of the company’s stock valued at $5,494,850,000 after acquiring an additional 146,654 shares in the last quarter. Farallon Capital Management LLC grew its stake in shares of Anthem by 27.3% during the second quarter. Farallon Capital Management LLC now owns 1,050,000 shares of the company’s stock valued at $296,321,000 after acquiring an additional 225,000 shares in the last quarter. Integre Asset Management LLC acquired a new stake in shares of Anthem during the second quarter valued at about $2,182,000. Finally, Cohen & Steers Inc. grew its stake in shares of Anthem by 66.2% during the second quarter. Cohen & Steers Inc. now owns 35,187 shares of the company’s stock valued at $9,930,000 after acquiring an additional 14,013 shares in the last quarter. 88.28% of the stock is currently owned by institutional investors and hedge funds.
Shares of ANTM stock traded down $1.02 during trading hours on Wednesday, hitting $256.27. 44,970 shares of the company were exchanged, compared to its average volume of 1,512,952. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.64 and a current ratio of 1.64. Anthem Inc has a one year low of $227.16 and a one year high of $317.99. The business’s 50-day simple moving average is $270.08 and its two-hundred day simple moving average is $279.36. The stock has a market capitalization of $65.82 billion, a price-to-earnings ratio of 16.14, a P/E/G ratio of 0.94 and a beta of 0.74.
Anthem (NYSE:ANTM) last issued its quarterly earnings results on Wednesday, July 24th. The company reported $4.64 EPS for the quarter, topping the consensus estimate of $4.61 by $0.03. Anthem had a net margin of 4.21% and a return on equity of 15.02%. The business had revenue of $25.20 billion for the quarter, compared to analysts’ expectations of $24.88 billion. During the same quarter last year, the company posted $4.25 earnings per share. The company’s quarterly revenue was up 10.9% compared to the same quarter last year. As a group, analysts anticipate that Anthem Inc will post 19.36 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be given a dividend of $0.80 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.20 annualized dividend and a dividend yield of 1.25%. Anthem’s payout ratio is 20.14%.
In other Anthem news, Director Robert L. Dixon, Jr. sold 520 shares of the firm’s stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $294.11, for a total value of $152,937.20. Following the transaction, the director now owns 9,971 shares of the company’s stock, valued at $2,932,570.81. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.17% of the company’s stock.
Several brokerages have recently weighed in on ANTM. Deutsche Bank began coverage on Anthem in a research note on Thursday, September 12th. They set a “buy” rating for the company. ValuEngine downgraded Anthem from a “hold” rating to a “sell” rating in a research note on Thursday, August 22nd. Wells Fargo & Co restated a “buy” rating on shares of Anthem in a research note on Friday, July 26th. Zacks Investment Research downgraded Anthem from a “buy” rating to a “hold” rating and set a $289.00 target price for the company. in a research note on Monday, August 19th. Finally, Morgan Stanley increased their price target on shares of Anthem from $359.00 to $371.00 and gave the stock an “overweight” rating in a research report on Friday, July 12th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and fourteen have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $325.93.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem Inc (NYSE:ANTM).
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.